ArticleBiomedicines2026

New Clinical Trials and Therapeutic Advances with Faricimab and Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: A Durability-Oriented Comparative Perspective.

Feliciana Menna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.